PMC:7796041 / 32326-32468 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"895","span":{"begin":82,"end":100},"obj":"Chemical"},{"id":"897","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A897","pred":"tao:has_database_id","subj":"897","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Additionally, individual specific therapy attemps with respect to COVID-19, e.g., hydroxochloroquine administration, were specified (Table 1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T256","span":{"begin":0,"end":142},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Additionally, individual specific therapy attemps with respect to COVID-19, e.g., hydroxochloroquine administration, were specified (Table 1)."}